Treatment of the mouse neuroblastoma cell line, N1E-115, with the HDAC inhibitor, valproic acid (VPA), has been shown to specifically upregulate Gadd45a protein expression and induce neurite outgrowth from these cells via activation of the MAP3K, MEKK4 [10]. Here, GADD45A is linked to neuroblastoma.